Stefania Carobbio

Stefania Carobbio

Auto-generated profile, based on publicly available information

Stefania Carobbio

Príncipe Felipe Research Centre (CIPF), 46012 Valencia, Spain

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 April 2024 in The EMBO Journal
Verified
Journal Article
Open access
JTJoycelyn Tan
Joycelyn Tan
SVSam Virtue
Sam Virtue
DNDougall M Norris
Dougall M Norris
OCOlivia J Conway
Olivia J Conway
MYMing Yang
Ming Yang
DFDaniel Fazakerley
Daniel Fazakerley
The in vitro oxygen microenvironment profoundly affects the capacity of cell cultures to model physiological and pathophysiological states. Cell culture is often considered to be hyperoxic, but pericellular oxygen levels, which are affected by oxygen diffusivity and consumption, are rarely reported. Here, we provide evidence that several cell types in culture actually experience local hypoxia, with important implications for cell metabolism and function. We focused initially on adipocytes, as adipose tissue hypoxia is frequently observed in obesity and precedes diminished adipocyte function. Under standard conditions, cultured adipocytes are highly glycolytic and exhibit a transcriptional profile indicative of physiological hypoxia. Increasing pericellular oxygen diverted glucose flux toward mitochondria, lowered HIF1α activity, and resulted in widespread transcriptional rewiring. Functionally, adipocytes increased adipokine secretion and sensitivity to insulin and lipolytic stimuli, recapitulating a healthier adipocyte model. The functional benefits of increasing pericellular oxygen were also observed in macrophages, hPSC-derived hepatocytes and cardiac organoids. Our findings demonstrate that oxygen is limiting in many terminally-differentiated cell types, and that considering pericellular oxygen improves the quality, reproducibility and translatability of culture models.

25 April 2022 in Nature Metabolism
Verified
Journal Article
Closed access
PDF file
VPV. Pellegrinelli
V. Pellegrinelli
SRS. Rodriguez-Cuenca
S. Rodriguez-Cuenca
CRC. Rouault
C. Rouault
EFElizabeth Figueroa-Juarez
Elizabeth Figueroa-Juarez
Hanna Marie SchilbertHanna Marie Schilbert
Hanna Marie Schilbert
AVAntonio Vidal-Puig
Antonio Vidal-Puig

18 September 2024
Verified
Book Chapter
Closed access
PDF file
SCStefania Carobbio
Stefania Carobbio
VPVanessa Pellegrinelli
Vanessa Pellegrinelli
AVAntonio Vidal-Puig
Antonio Vidal-Puig

24 April 2023 in Current Opinion in Genetics & Development
Verified
Journal Article
Open access
JNJaime Navarro-Perez
Jaime Navarro-Perez
AVAntonio Vidal-Puig
Antonio Vidal-Puig
SCStefania Carobbio
Stefania Carobbio
The white adipose tissue's primary roles are to store and mobilise energy, which is very different from the brown adipose tissue's function of using fuel to generate heat and maintain the body temperature. The adipose tissues (ATs), co-ordinately with the other organs, sense energetic demands and inform of their reserves before embarking on energetically demanding physiological functions. It is not surprising that ATs exhibit highly integrated regulatory mechanisms mediated by a diversified secretome, including adipokines, lipokines, metabolites and a repertoire of extracellular miRNAs that contribute to integrating the function of the AT niche and connect the AT through paracrine and endocrine effects with the whole organism. Characterising the adipose secretome, its changes in health and disease, regulation by ageing and gender and their contribution to energy homoeostasis is necessary to optimise its use for personalised strategies to prevent or reverse metabolic diseases.

4 September 2025 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
CTChristopher P. Thomas
Christopher P. Thomas
VTVictoria J. Tyrrell
Victoria J. Tyrrell
JBJames J. Burston
James J. Burston
SJSam R. C. Johnson
Sam R. C. Johnson
MAMaceler Aldrovandi
Maceler Aldrovandi
VOValerie B. O’Donnell
Valerie B. O’Donnell
12/15-lipoxygenase (12/15-LOX, Alox15 ) generates bioactive oxygenated lipids during inflammation, however its homeostatic role(s) in normal healing are unclear. Here, the role of 12/15-LOX in resolving skin wounds was elucidated, focusing on how its lipids act together in physiologically relevant amounts. In mice, wounding caused acute appearance of 12/15-LOX-expressing macrophages and stem cells, coupled to early generation of ~12 monohydroxy-oxylipins and enzymatically oxidized phospholipids (eoxPL). Alox15 deletion increased collagen deposition, stem cell/fibroblast proliferation, IL6/pSTAT3, pSMAD3, and interferon (IFN)-γ levels. Conversely, CD206 expression, F480+ cells, and MMP9 and MMP2 activities were reduced. Alox15 −/− skin was deficient in PPARγ/adiponectin activity. Furthermore, while pro-inflammatory genes were upregulated as normal during wounding, many including Il6, Il1b, ccl4, Cd14, Cd274, Clec4d, Clec4e, Csf3, Cxcl2, and miR-21 failed to revert to baseline during healing, indicating disruption of PPARγ’s anti-inflammatory brake on NLRP3/inflammasome and TGF-β signaling. Reconstituting Alox15 −/− wounds with a physiological mixture of Alox15 -derived primary oxylipins generated by healing wounds restored MMP and dampened collagen deposition. The oxylipin mixture activated the PPARγ response element in vitro, while in vivo, its coactivator, Helz2 , was significantly upregulated as well as several fatty acid and prostaglandin PPARγ ligands. Additional inflammatory and proliferative gene networks impacted by Alox15 −/− included Elf4, Cebpb , and Tcf3. In summary, 12/15-LOX generates abundant monohydroxy oxylipins that act together via PPARγ. The identification of multiple gene alterations reveals several targets for treating nonhealing wounds. Our studies demonstrate that 12/15-LOX oxylipins act in concert, dampening inflammation in vivo, revealing the need to consider lipid signaling holistically.

2 March 2024 in Biochemical Pharmacology
Verified
Journal Article
Open access
JNJaime Navarro-Perez
Jaime Navarro-Perez
SCStefania Carobbio
Stefania Carobbio
The primary role of adipose tissue stem cells (ADSCs) is to support the function and homeostasis of adipose tissue in physiological and pathophysiological conditions. However, when ADSCs become dysfunctional in diseases such as obesity and cancer, they become impaired, undergo signalling changes, and their epigenome is altered, which can have a dramatic effect on human health. In more recent years, the therapeutic potential of ADSCs in regenerative medicine, wound healing, and for treating conditions such as cancer and metabolic diseases has been extensively investigated with very promising results. ADSCs have also been used to generate two-dimensional (2D) and three-dimensional (3D) cellular and in vivo models to study adipose tissue biology and function as well as intracellular communication. Characterising the biology and function of ADSCs, how it is altered in health and disease, and its therapeutic potential and uses in cellular models is key for designing intervention strategies for complex metabolic diseases and cancer.